Bronchiolitis: From empiricism to scientific evidence

Minerva Pediatrica

Volumn 61, Issue 2, 2009, Pages 217-225

  Carraro, S ^a   Zanconato, S ^a   Baraldi, E ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bronchiolitis, diagnosis; Guideline adherence; Respiratory syncytial viruses; Respiratory tract infections

Indexed keywords

ADRENALIN; AZITHROMYCIN; BRONCHODILATING AGENT; CAFFEINE; CLARITHROMYCIN; CORTICOSTEROID; DEOXYRIBONUCLEASE; DEXAMETHASONE; FUROSEMIDE; LEVALBUTEROL; METHYLXANTHINE; METHYLXANTHINE DERIVATIVE; MONTELUKAST; PALIVIZUMAB; RIBAVIRIN; SALBUTAMOL; SMALL INTERFERING RNA; SODIUM CHLORIDE; THEOPHYLLINE;

APNEA; BRONCHIOLITIS; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; HUMAN; PRACTICE GUIDELINE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SINGLE DRUG DOSE; VIRUS IDENTIFICATION;

EID: 67649544572     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. th edition. London: Elsevier Saunders; 2000.
2. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-1793
3. Scottish Intercollegiate Guidelines Network (SIGN). Bronchiolitis in children. NHS Quality Improvement Scotland [Internet] Available from www.sign.ac.uk [cited January 16, 2009].
4. Kneyber MC, Brandenburg AH, de Groot R, Joosten KF, Rothbarth PH, Ott A et al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr 1998;157:331-335 (Pubitemid 28178138)
5. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC)prospective study of risk factors and outcomes in patients hospitalized withrespiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126:212-9.
6. Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003;349:27-35. (Pubitemid 36765100)
7. Rosen LM, Yamamato LG, Wiebe RA. Pulse oximetry to identify a high-risk group of children with wheezing. Am J Emerg Med 1989;7:567-570 (Pubitemid 19276846)
8. Schroeder AR, Marmor A, Newman TB. Pulse oximetry in bronchiolitis patients. Pediatrics 2003;112(6 Pt 1):1463. (Pubitemid 37523448)
9. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006;368:312-322
10. Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics 2005;115:878-884
11. Schweich PJ, Hurt TL, Walkley EI, Mullen N, Archibald LF. The use of nebulized albuterol in wheezing infants. Pediatr Emerg Care 1992;8:184-188
12. Schuh S, Canny G, Reisman JJ, Kerem E, Bentur L, Petric M et al. Nebulized albuterol in acute bronchiolitis. J Pediatr 1990;117:633-637 (Pubitemid 20332112)
13. Gadomski AM, Lichtenstein R, Horton L, King J, Keane V, Permutt T. Efficacy of albuterol in the management of bronchiolitis. Pediatrics 1994;93:907-912 (Pubitemid 24163336)
14. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991;118:807-811
15. Dobson JV, Stephens-Groff SM, McMahon SR, Stemmler MM, Brallier SL, Bay C. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics 1998;101:361-368 (Pubitemid 28136407)
16. Levin DL, Garg A, Hall LJ, Slogic S, Jarvis JD, Leiter JC. A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory syncytial virus bronchiolitis on mechanical ventilation. Pediatr Crit Care Med 2008;9:598-604.
17. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004;CD003123.
18. Walsh P, Caldwell J, McQuillan KK, Friese S, Robbins D, Rothenberg SJ. Comparison of nebulized epinephrine to albuterol in bronchiolitis. Acad Emerg Med 2008;15:305-313
19. Panickar J. Best BETs from the Manchester Royal Infirmary. BET 2. Is nebulised salbutamol indicated in bronchiolitis? Emerg Med J 2008;25:840-841
20. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004;CD004878
21. Corneli HM, Zorc JJ, Mahajan P, Shaw KN, Holubkov R, Reeves SD et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007;357:331-339 (Pubitemid 47124133)
22. Teeratakulpisarn J, Limwattananon C, Tanupattarachai S, Limwattananon S, Teeratakulpisarn S, Kosalaraksa P. Efficacy of dexamethasone injection for acute bronchiolitis in hospitalized children: a randomized, double-blind, placebo-controlled trial. Pediatr Pulmonol 2007;42:433-439 (Pubitemid 46700941)
23. Korppi M. How should we study responses to treatment in children with bronchiolitis? Pediatr Pulmonol 2007;42:984-985
24. Blom D, Ermers M, Bont L, van Aalderen WM, van Woensel JB. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev 2007;CD004881.
25. King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN et al. Pharmacologic treatment of bronchiolitis in infants and children. Arch Pediatr Adolesc Med 2004;158:127-137
26. Edell D, Khoshoo V, Ross G, Salter K. Early ribavirin treatment of bronchiolitis. Chest 2002;122:935-939
27. Chen CH, Lin YT, Yang YH, Wang LC, Lee JH, Kao CL et al. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatr Allergy Immunol 2008;19:166-172 (Pubitemid 351197291)
28. Rodriguez WJ, Arrobio J, Fink R, Kim HW, Milburn C. Prospective follow-up and pulmonary functions from a placebocontrolled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Arch Pediatr Adolesc Med 1999; 153:469-474 (Pubitemid 29220395)
29. Long CE, Voter KZ, Barker WH, Hall CB. Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin and placebo. Pediatr Infect Dis J 1997;16:1023-1028 (Pubitemid 27494955)
30. Friis B, Andersen P, Brenoe E, Hornsleth A, Jensen A, Knudsen FU et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984;59:1038-1045
31. Field CM, Connolly JH, Murtagh G, Slattery CM, Turkington EE. Antibiotic treatment of epidemic bronchiolitis - a double-blind trial. Br Med J 1966;1:83-85
32. Spurling GK, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev 2007;CD005189.
33. Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J 2007;29:91-97 (Pubitemid 46092003)
34. Kneyber MC, van Woensel JB, Uijtendaal E, Uiterwaal CS, Kimpen JL; Dutch Antibiotics in RSV Trial (DART) Research Group. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: a randomized equivalence trial. Pediatr Pulmonol 2008;43:142-149
35. Mandelberg A. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis. Pediatrics 2008;122:e1249-55.
36. Bisgaard H; Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-383
37. Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am J Respir Crit Care Med 2008;178:854-860
38. Kuzik BA, Al-Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S et al. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 2007;151:266-270 (Pubitemid 47284136)
39. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2008;CD006458.
40. Boogaard R, Hulsmann AR, van Veen L, Vaessen-Verberne AA, Yap YN, Sprij AJ et al. Recombinant human deoxyribonuclease in infants with respiratory syncytial virus bronchiolitis. Chest 2007;131:788-95. (Pubitemid 46446871)
41. Bar A, Srugo I, Amirav I, Tzverling C, Naftali G, Kugelman A. Inhaled furosemide in hospitalized infants with viral bronchiolitis: a randomized, double-blind, placebo-controlled pilot study. Pediatr Pulmonol 2008;43:261-267
42. Ramesh P, Samuels M. Are methylxanthines effective in preventing or reducing apnoeic spells in infants with bronchiolitis? Arch Dis Child 2005;90:321-322
43. Yanney M, Vyas H. The treatment of bronchiolitis. Arch Dis Child 2008;93:793-798
44. Gozal D, Colin AA, Jaffe M, Hochberg Z. Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis. Pediatr Res 1990;27:204-209- (Pubitemid 20044543)
45. van Steensel-Moll HA, Hazelzet JA, van der Voort E, Neijens HJ, Hackeng WH. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child 1990;65:1237-1239 (Pubitemid 20356893)
46. Perrotta C, Ortiz Z, Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev 2007;CD004873. (Pubitemid 351820410)
47. Pullan CR, Toms GL, Martin AJ, Gardner PS, Webb JK, Appleton DR. Breastfeeding and respiratory syncytial vims infection. Br Med J 1980;281:1034-1036 (Pubitemid 10006902)
48. McConnochie KM, Roghmann KJ. Breast feeding and maternal smoking as predictors of wheezing in children age 6 to 10 years. Pediatr Pulmonol 1986;2:260-268
49. Sattar SA, Terro J, Vashon R, Keswick B. Hygienic handantiseptics: should they not have activity and label claims against viruses? Am J Infect Control 2002;30:355-372
50. [No authors listed]. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 1998;102:531-537
51. Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003;143:532-540 (Pubitemid 37352516)
52. Fuller H, Del Mar C. Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database Syst Rev 2006;CD004883.
53. th edition. Elk Grove Village, IL: American Academy of Pediatrics; 2006.